Page last updated: 2024-10-24

negative regulation of immunological synapse formation

Definition

Target type: biologicalprocess

Any process that stops, prevents or reduces the frequency, rate or extent of immunological synapse formation. [GOC:obol]

Negative regulation of immunological synapse formation is a complex process involving the suppression of molecular interactions and signaling pathways that contribute to the formation of the immunological synapse. The immunological synapse is a specialized structure formed between an immune cell, such as a T cell, and an antigen-presenting cell, such as a dendritic cell. It facilitates the transfer of information between the cells, leading to T cell activation and immune responses.

The formation of the immunological synapse is a highly regulated process, with various mechanisms in place to ensure its appropriate timing and activation. Negative regulation of this process is crucial to prevent inappropriate activation of immune cells and maintain immune homeostasis. This regulation is achieved through a variety of mechanisms, including:

1. **Inhibition of adhesion molecules:** Proteins like CD2 and LFA-1 play key roles in cell-cell adhesion, contributing to the formation of the immunological synapse. Their interactions are tightly controlled by various inhibitory mechanisms. For example, inhibitory receptors like CTLA-4 and PD-1 can bind to these adhesion molecules and block their activation, hindering synapse formation.

2. **Suppression of signaling pathways:** The formation of the immunological synapse triggers downstream signaling pathways, ultimately leading to T cell activation. Negative regulators target these signaling cascades at various points. For instance, the phosphatase SHP-1 can dephosphorylate key signaling molecules, such as ZAP-70, interrupting the signaling cascade.

3. **Modulation of cytoskeletal dynamics:** The reorganization of the cytoskeleton is essential for the formation of the immunological synapse. Negative regulators can influence cytoskeletal dynamics by modulating the activity of proteins involved in cytoskeleton remodeling, such as actin-binding proteins.

4. **Induction of inhibitory signals:** Some negative regulators directly induce inhibitory signals, preventing the activation of T cells. For example, the cytokine TGF-β can suppress T cell activation by promoting the expression of inhibitory receptors.

In summary, the negative regulation of immunological synapse formation involves a multifaceted interplay of mechanisms that control cell adhesion, signaling pathways, cytoskeletal dynamics, and the induction of inhibitory signals. This intricate regulation ensures the appropriate control of immune responses, preventing excessive activation and maintaining immune homeostasis.'
"

Proteins (2)

ProteinDefinitionTaxonomy
Hepatitis A virus cellular receptor 2A hepatitis A virus cellular receptor 2 that is encoded in the genome of human. [PRO:DNx, UniProtKB:Q8TDQ0]Homo sapiens (human)
Galectin-3A galectin-3 that is encoded in the genome of human. [PRO:DNx, UniProtKB:P17931]Homo sapiens (human)

Compounds (10)

CompoundDefinitionClassesRoles
lactosebeta-lactose : The beta-anomer of lactose.

lactose : A glycosylglucose disaccharide, found most notably in milk, that consists of D-galactose and D-glucose fragments bonded through a beta-1->4 glycosidic linkage. The glucose fragment can be in either the alpha- or beta-pyranose form, whereas the galactose fragment can only have the beta-pyranose form.

Lactose: A disaccharide of GLUCOSE and GALACTOSE in human and cow milk. It is used in pharmacy for tablets, in medicine as a nutrient, and in industry.
lactose
methyl alpha-d-galactopyranosidemethyl alpha-D-galactoside : An alpha-D-galactoside having a methyl substituent at the anomeric position.

methyl-galactopyranoside: structure in first source
alpha-D-galactoside;
methyl D-galactoside;
monosaccharide derivative
methyl beta-galactosidemethyl beta-D-galactoside : A beta-D-galactopyranoside having a methyl substituent at the anomeric position.

methyl beta-galactoside: RN given refers to (beta-D)-isomer

methyl galactoside : A methyl glycoside in which the H of the OH group on C-1 of galactose is replaced by a methyl group.
beta-D-galactoside;
methyl D-galactoside;
monosaccharide derivative
thiodigalactosidethiodigalactoside: RN given refers to beta-D-galactopyranoside (D-Gal)-isomer
methyl lactosidebeta-D-Gal-(1->4)-beta-D-Glc-OMe : A methyl glycoside comprising methyl beta-D-glucoside having an beta-D-galactosyl residue at the 4-position.disaccharide derivative;
methyl glycoside
n-acetyllactosamineN-acetyllactosamine : A beta-D-galactopyranosyl-(1->4)-N-acetyl-D-glucosamine having beta-configuration at the reducing end anomeric centre.

N-acetyllactosamine: RN given refers to D-isomer
beta-D-Galp-(1->4)-D-GlcpNAc
galactosealpha-D-galactoside : Any D-galactoside having alpha-configuration at its anomeric centre.D-galactopyranosemouse metabolite
5-chloro-1h-benzimidazole-2-thiol5-chloro-1H-benzimidazole-2-thiol: trypanocidal
galactalgalactal: RN given refers to cpd with unspecified isomeric designation; structureanhydrohexose;
glycal
pf-2545920